Late-onset schizophrenia
Abstract
In recent years, late-onset schizophrenia is a subject of controversial debate in the medical profession largely due to difficulties in reaching a consensus on the diagnosis of the disorder. In the present article we try to summarize in one place the scientific resources that were studying this disorder in the past decades and present a comprehensive overview from diagnosis to treatment of this relatively common disorder. Late-onset schizophrenia differs from early-onset schizophrenia in terms of symptoms, treatment, prognosis and pathogenesis, which is in early-onset schizophrenia based mainly on the developmental causes, whereas late-onset schizophrenia is most likely the result of a degenerative process within the central nervous system. Differential diagnosis of this disorder can be especially challenging and therefore demands additional attention. It is necessary to exclude degenerative diseases, expansive processes, neurological and psychiatric disorders, and ultimately, the abuse of psychoactive substances. Lately, there has been a lot of research done on genetic causes that could explain pathogenesis of the disorder, however, knowledge of the genetic influence for the establishment of clinical diagnosis is at this moment still inadequate. Thus, a clinical examination of the patient still remains the gold standard for the diagnosis of late-onset schizophrenia. Finally, we highlight the particularities of pharmacotherapy and summarize the current treatment guidelines for late-onset schizophrenia.
Downloads
References
Iglewicz A, Meeks TW, Jeste DV. New wine in old bottle: late-life psychosis. Psychiatr Clin North Am. 2011 Jun;34(2):295–318. https://doi.org/10.1016/j.psc.2011.02.008 PMID:21536160
Reinhardt MM, Cohen CI. Late-Life Psychosis: Diagnosis and Treatment. Curr Psychiatry Rep. 2015 Feb;17(2):1. http://www.ncbi.nlm.nih.gov/pubmed/25617038.
Rajji TK, Mulsant BH. Nature and course of cognitive function in late-life schizophrenia: a systematic review. Schizophr Res. 2008 Jul;102(1–3):122–40. https://doi.org/10.1016/j.schres.2008.03.015 PMID:18468868
Moran M, Lawlor B. Late-life Schizophrenia. Am J Psychiatry. 2005;4(11):51–5.
Boyce N, Walker Z. Late-onset schizophrenia and very late-onset schizophrenia-like psychosis. Am J Psychiatry. 2008;7(11):463–6.
Brichant-Petitjean C, Legauffre C, Ramoz N, Ades J, Gorwood P, Dubertret C. Memory defcits in late-onset schizophrenia. Schizophr Res. 2013 Dec;151(1–3):85–90. https://doi.org/10.1016/j.schres.2013.08.021 PMID:24129041
Howard R, Rabins PV, Seeman MV, Jeste DV; Te International Late-Onset Schizophrenia Group. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. Am J Psychiatry. 2000 Feb;157(2):172–8. https://doi.org/10.1176/appi.ajp.157.2.172 PMID:10671383
Sato T, Bottlender R, Schröter A, Möller HJ. Psychopathology of early-onset versus late-onset schizophrenia revisited: an observation of 473 neuroleptic-naive patients before and after first-admission treatments. Schizophr Res. 2004 Apr;67(2–3):175–83. https://doi.org/10.1016/S0920-9964(03)00015-X PMID:14984876
Sharma ER, Debsikdar AV, Naphade NM, Shetty JV. Very Late-onset Schizophrenia Like Psychosis: Case Series and Future Directions. Indian J Psychol Med. 2014 Apr;36(2):208–10. https://doi.org/10.4103/0253-7176.130999 PMID:24860229
Vahia IV, Palmer BW, Depp C, Fellows I, Golshan S, Kraemer HC, et al. Is late-onset schizophrenia a subtype of schizophrenia? Acta Psychiatr Scand. 2010 Nov;122(5):414–26. https://doi.org/10.1111/j.1600-0447.2010.01552.x PMID:20199491
Lloret M, Harto M, Tatay A, Almonacid C, Castillo A, Calabuig R. Late-onset schizophrenia: a case report. Eur Psychiatry. 2011;26 Suppl.1:841. https://doi.org/10.1016/S0924-9338(11)72546-9.
Roth M. Late paraphrenia, past and present. Biol Psychiatry. 1996;39(7):511. https://doi.org/10.1016/0006-3223(96)83990-4.
Holt AE, Albert ML. Cognitive neuroscience of delusions in aging. Neuropsychiatr Dis Treat. 2006 Jun;2(2):181–9. https://doi.org/10.2147/nedt.2006.2.2.181 PMID:19412462
Köhler S, van Os J, de Graaf R, Vollebergh W, Verhey F, Krabbendam L. Psychosis risk as a function of age at onset: a comparison between early- and late-onset psychosis in a general population sample. Soc Psychiatry Psychiatr Epidemiol. 2007 Apr;42(4):288–94. https://doi.org/10.1007/s00127-007-0171-6 PMID:17370045
Fénelon G. [Visual hallucinations: the Charles Bonnet syndrome]. Psychol Neuropsychiatr Vieil. 2003 Jun;1(2):121–7. PMID:15683948
Silverstein SM, Wang Y, Keane BP. Cognitive and neuroplasticity mechanisms by which congenital or early blindness may confer a protective effect against schizophrenia. Front Psychol. 2013 Jan;3(624):624. PMID:23349646
Schubert EW, Henriksson KM, McNeil TF. A prospective study of offspring of women with psychosis: visual dysfunction in early childhood predicts schizophrenia-spectrum disorders in adulthood. Acta Psychiatr Scand. 2005 Nov;112(5):385–93. https://doi.org/10.1111/j.1600-0447.2005.00584.x PMID:16223427
Karim S, Byrne EJ. Treatment of psychosis in elderly people. Adv Psychiatr Treat. 2005;11(4):289–96. https://doi.org/10.1192/apt.11.4.286.
Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008 May;31(5):234–42. https://doi.org/10.1016/j.tins.2008.02.005 PMID:18395805
Kantrowitz JT, Javitt DC. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull. 2010 Sep;83(3–4):108–21. https://doi.org/10.1016/j.brainresbull.2010.04.006 PMID:20417696
Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry. 2012 Sep;17(9):887–905. https://doi.org/10.1038/mp.2012.37 PMID:22584867
Folsom DP, Lebowitz BD, Lindamer LA, Palmer BW, Patterson TL, Jeste DV. Schizophrenia in late life: emerging issues. Dialogues Clin Neurosci. 2006;8(1):45–52. PMID:16640113
Copyright (c) 2018 Slovenian Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.